Skip to main content

Table 3 Distribution of HR-HPV genotypes in study participants

From: Prevalence and distribution of human papillomavirus genotypes among women attending gynecology clinics in northern Henan Province of China

HPV type Single infection Double infections Multiple infections Total infections
Positive no % (95% CI) Positive no % (95% CI) Positive no % (95% CI) % (95% CI)
HPV16 380 2.4 (2.2–2.7) 184 1.2 (1.0–1.3) 105 0.7 (0.5–0.8) 4.3 (4.0–4.6)
HPV52 185 1.2 (1.0–1.4) 98 0.6 (0.5–0.8) 269 1.7 (1.5–1.9) 3.5 (3.2–3.8)
HPV58 144 0.9 (0.8–1.1) 106 0.7 (0.5–0.8) 61 0.4 (0.3–0.5) 2.0 (1.8–2.2)
HPV53 138 0.9 (0.7–1.0) 81 0.5 (0.4–0.6) 59 0.4 (0.3–0.5) 1.8 (1.6–2.0)
HPV39 95 0.6 (0.5–0.7) 90 0.6 (0.5–0.7) 45 0.3 (0.2–0.4) 1.5 (1.3–1.7)
HPV51 88 0.6 (0.4–0.7) 69 0.4 (0.3–0.5) 61 0.4 (0.3–0.5) 1.4 (1.2–1.6)
HPV18 96 0.6 (0.5–0.7) 32 0.2 (0.1–0.3) 40 0.3 (0.2–0.3) 1.1 (0.9–1.2)
HPV33 74 0.5 (0.4–0.6) 53 0.3 (0.2–0.4) 32 0.2 (0.1–0.3) 1.0 (0.9–1.2)
HPV31 70 0.4 (0.3–0.6) 46 0.3 (0.2–0.4) 29 0.2 (0.1–0.3) 0.9 (0.8–1.1)
HPV68 57 0.4 (0.3–0.5) 38 0.2 (0.2–0.3) 27 0.2 (0.1–0.2) 0.8 (0.6–0.9)
HPV66 55 0.4 (0.3–0.4) 31 0.2 (0.1–0.3) 33 0.2 (0.1–0.3) 0.8 (0.6–0.9)
HPV56 43 0.3 (0.2–0.4) 33 0.2 (0.1–0.3) 35 0.2 (0.1–0.3) 0.7 (0.6–0.8)
HPV59 27 0.2 (0.1–0.2) 20 0.1 (0.1–0.2) 23 0.1 (0.1–0.2) 0.4 (0.3–0.6)
HPV45 38 0.2 (0.2–0.3) 10 0.1 (0.0–0.1) 10 0.1 (0.0–0.1) 0.4 (0.3–0.5)
HPV35 18 0.1 (0.1–0.2) 10 0.1 (0.0–0.1) 12 0.1 (0.0–0.1) 0.3 (0.2–0.3)
HPV82 14 0.1 (0.0–0.1) 15 0.1 (0.0–0.1) 8 0.1 (0.0–0.1) 0.2 (0.2–0.3)
HPV26 15 0.1 (0.0–0.1) 13 0.1 (0.0–0.1) 5 0.0 (0.0–0.1) 0.2 (0.1–0.3)